Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

The Wegovy pill launched Monday, and the starting dose is now available at pharmacies around the country with higher doses arriving by the end of the week. The Food and Drug Administration approved ...

Americans can now purchase a starter dose of Novo Nordisk’s weight loss drug Wegovy in pill form, the company announced Monday, pledging widespread availability. The 1.5 milligram starter dose of a ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

Weight-loss drug Wegovy is now available in the form of a pill in the United States, the Scandinavian drug-maker Novo Nordisk announced on Monday, Jan. 5. The first-of-its kind pill offers 1.5 and 4 ...

The Wegovy pill is the first and only oral GLP-1 for weight loss in adults. The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced ...

Novo Nordisk launched the first GLP-1 weight-loss pill Monday with a pledge that manufacturing investments will enable the drugmaker to avoid the type of shortages that plagued the rollout of its ...

The new Wegovy pill was just approved in the US—and it’s the first oral GLP-1 for weight management on the market. Trials suggest it’s approximately as effective as the injectable form, and it has ...

The U.S. Food and Drug Administration-approved Wegovy pill will be here before you'd think. Fresh off winning approval from the FDA in December, Wegovy manufacturer Novo Nordisk says it will have the ...

This is read by an automated voice. Please report any issues or inconsistencies here. U.S. regulators this week gave the green light to a pill version of the ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...